INTRODUCTION
Retroviruses, the etiological agents of several forms of cancer and AIDS, encode an RNA-dependent DNA polymerase (reverse transcriptase) that carries several enzymatic functions : RNAdirected DNA synthesis of viral DNA minus strand, DNAdirected DNA synthesis of the plus strand of the proviral DNA and an RNase H activity [1] [2] [3] [4] [5] . This activity is responsible for viral RNA degradation once the minus strand DNA synthesis has occured. After the RNA moiety removal, the minus strand becomes available as a template for the synthesis of the DNA plus strand. This RNase H activity has been also implicated in releasing tRNA primer and in nicking viral RNA to generate the polypurine-rich oligonucleotide that primes plus-strand DNA synthesis [6, 7] .
As with all DNA polymerases, reverse transcriptase needs a primer carrying a 3' OH free group to initiate cDNA synthesis. Concerning the viral first strand DNA synthesis from an RNA template, the in vivo primer has been shown to be tRNA [8] [9] [10] . A region, near the 5' end of the retroviral RNA genome ('primer binding site' or PBS), is complementary to the last 18 nucleotides of the 3' CCA end of the specific primer.
Avian myeloblastosis virus (AMV) reverse transcriptase uses host tRNA Tr P as primer while the Moloney murine leukemia virus (M-MuLV) enzyme uses tRNA Pro . In the case of human immunodeficiency virus (HIV), tRNA 1^3 is most probably the primer as deduced from the retroviral genome nucleotide sequence [11] . Previous work has shown that avian reverse transcriptase is involved in the selection of tRNA Tr P and its annealing to the avian retrovirus PBS [12, 13] . More recently we have shown that a retrovirus-encoded small molecular weight nucleic acid binding protein can stimulate the in vitro tRNA-PBS annealing [14] .
HTV reverse transcriptase is isolated as a 66-51 kDa (p66 and p51) dimer from the viral particle. The p51 subunit is derived from p66 form. The maturation occurs by partial proteolysis by the virus encoded acid protease which also cleaves the gag-pol precursor [15] [16] [17] [18] . A recombinant HIV reverse transcriptase * To whom correspondence should be addressed expressed in transformed yeast cells [16] was biochemically characterized. Furthermore we showed that the p66-p51 enzyme can form a stable complex with bovine tRNA Lys [19] . During the synthesis of a natural primer-template complex using bovine tRNA Lys and a viral RNA fragment carrying the PBS site, we observed a strong inhibition of cDNA synthesis by free tRNA L y s . The same effect has been observed with activated DNA or a natural RNA template, while no inhibition was observed with the synthetic poly(rA)-oligo(dT) template, routinely used for assaying reverse transcriptase [19] .
In this article we have pursued a detailed study of the effect of several purified tRNAs on the mature (p66-p51) and precursor (p66) forms of HIV reverse transcriptase, as well as on other DNA polymerases.
MATERIALS AND METHODS Materials
Unlabelled nucleotides, oligonucleotides or polynucleotides were obtained from Sigma or Pharmacia. Radioisotopes were purchased from Commissariat a l'Energie Atomique-Saclay (CEA-France). AMV reverse transcriptase was purchased from Genofit. T7 RNA polymerase, PstI and SphI restriction enzymes and Ti ribonuclease were purchased from BRL, proteinase K from Boehringer and pancreatic ribonuclease A from Sigma. Xenopus laevis oocytes DNA polymerases a and y were purified as described previously [20 and 19 respectively [22] . The purity of each tRNA was determined by its aminoacylation level using a pool of amynoacyl-tRNA synthetases prepared from wheat germ as described by Nishimura and Weinstein [23] . The purified tRNAs showed an aminoacylation level between 1200 and 1600 picomoles per 260 nm absorbancy unit.
HIV reverse transcriptase purification HIV reverse transcriptase p66/p51 form was obtained as before [19] . HIV reverse transcriptase p66 form was purified as described previously for the p66/p51 form, but using a proteasedeficient yeast strain (JSC 302, derivative of AB 116 : MATa, Ieu2-, trp-1, ura3-52, prBl-1122, pep4-3, prCl-407 [cir°]) transformed with the expression vector pBS24RT5. The parent vector, pBS24, has been described previously [24] .
Reverse transcriptase assays Incubation was carried out at 37°C for various times: a) In the presence of poly(rA)-oligo(dT), the reaction mixture contained in a final volume of 0.05 ml, 50 mM Tris-HCl pH 8.0, 10 mM MgCl 2 , 10 mM dithiothreitol, 80 mM KC1, 20/tg/ml of poly(rA)-oligo(dT), 0. Reactions were stopped by the addition of 1 ml of cold 10 % trichloroacetic acid plus 0.1 M sodium pyrophosphate. The precipitates were filtered through nitrocellulose membranes, washed with 2 % trichloroacetic acid, dried and counted in a PPO/POPOP/toluene scintillation mixture.
Animal DNA polymerase assays Incubations were performed with calf thymus activated DNA under the same conditions as for reverse transcriptase.
Purification of 'PBS' HTV RNA A 1.1 Kbp DNA fragment, containing R, U5 and PBS HIV sequences (gift from Dr. J.L. Darlix ; CNRS-Toulouse), was cloned in the PstI site of a Bluescribe plasmid. After SphI vector linearization, the insert was transcribed by T7 RNA polymerase. About 1 ng of linearized DNA was incubated with T7 RNA polymerase buffer, 50 mM DTT, 150 ;tM of each rXTP, 35 units/jtl of RNasin and 5 units//il of T7 RNA polymerase in a final volume of 50 /il for 1 hour at 37 °C. The reaction was stopped by adding 100 /tg/ml of proteinase K for 15 min at 37°C.
Transcription products were extracted twice with phenol, twice with phenol/chloroform/isoamyl alcohol (v/v/v : 24/24/1) and precipitated in 2.5 volumes of ethanol. RNA/DNA pellet was then washed with 70 % ethanol and resuspended in sterile water. After heating for 2 min at 85°C the solution was cooled rapidly, loaded on a cesium chloride solution (5.7 M) and centrifuged for 12 hours at 170,000xg. RNA was recovered from the bottom of the tube, resuspended and precipitated in 2.5 volumes of ethanol.
Ribonucleases digestions
RNase A: 0.1 unit A 260 of denatured tRNA (2 mg/ml tRNA in 0.1 M NaCl, heated for 5 min at 60°C and cooled in ice) was incubated with 6 units of RNase A for 30 min at 37°C.
Tj RNase: 0.1 unit A260 of denatured tRNA was incubated with 600 units of T, RNase for 30 min at 47°C.
Reactions were stopped by phenol extraction.
Urea-PAGE analysis 8 M urea-polyacrylamide gels were composed of two parts : a 8 % polyacrylamide stacking gel and a 20 % polyacrylamide separating gel. Samples were dried and resuspended in sample buffer (50 % sucrose, 0.2 % bromophenol blue, 0.2 % xylene cyanol, 8 M urea) and migration buffer TBE (450 mM Tris, 450 mM borate, 10 mM EDTA, pH 8.0). Migration was performed for 16 hours at 250 V. Silver nitrate staining was performed according to Igloi [25] , except that development was with a 0.28 % formaldehyde-0.75 M KOH solution. The reaction was stopped by 2.3 M citrate.
Oligonucleotide purification
When the purification of the 12 and 14-mers (T| RNase tRNA Lys digestion products) was needed, gels were stained with methylene blue (this type of staining allows tRNA aminoacylation after its elution from the gel). Acrylamide sections containing oligonucleotide bands were eluted in elution buffer (0.5 M ammonium acetate, 1 mM EDTA, 0.1 % SDS). Oligonucleotides were then precipitated in 2.5 volumes of ethanol and 0.3 M of sodium acetate, pH 5.2.
Production of anti-RT antibodies
Polyclonal antibodies against highly purified HIV RT (FPLC fractions [19] ) were prepared according to Vaitukaitis method [26] . 100 ng of RT were injected twice in the back of rabbits, with a period of three weeks between the two injections. The rabbits were then immunized with 50 ng of RT every two weeks. Antibody levels were checked a week after each injection using the ELISA technique. When anti-RT antibodies level reached a maximum, animals were sacrified.
Immunoblotting
Proteins or peptides were separated by electrophoresis on a 12% polyacrylamide-SDS gel [27] . Proteins were then transferred to Immobilon membranes (0.45 /*M Millipore) for three hours in a buffer containing 10 mM Caps, pH 11.0, 10% methanol. Blots were saturated in buffer A (10 mM phosphate buffer pH 7.0, 140 mM NaCl) with 1 % bovine serum albumin for three hours at room temperature and incubated with anti-RT antibodies (dilution 1/5000 in buffer A plus 0.3% bovine serum albumin). Blots were then rinsed in buffer A and incubated overnight in peroxidase linked goat anti-rabbit IgG (purchased from Pasteur Institute) for 1 hour at 37°C. After rinsing in buffer A, development was performed according to Hawkes et al'. [28] using chloronaphtol (Sigma) as substrate for peroxidase. In order to develop an in vitro assay using a natural primertemplate, we have synthesized a short fragment of 1100 nucleotides carrying the PBS site using the T7 RNA polymerase system. Beef liver purified tRNA fragment and cDNA synthesis was measured. As seen in Figure  1 , only when the primer/template ratio was 1 (about 10 nM) or less, an expected DNA synthesis increase was observed. The high incorporation obtained in the absence of primer tRNA is probably due to the presence of a high degree of secondary structure in the RNA fragment [29] . Using the same template, AMV reverse transcriptase also gave very high incorporation values without primer tRNA Lys indicating that the high background was related to the RNA and not to HIV transcriptase.
RESULTS AND DISCUSSION
A strong DNA synthesis inhibition was observed as soon as an excess of tRNA was present in the incubation mixture ; thus, less than 10% of residual activity was detected at 50 nM tRNA. As previously shown, a similar inhibition by tRNA L y s was obtained when calf thymus activated DNA or a plant virus RNA (turnip yellow mosaic virus, TYMV) were used as templates with HIV reverse transcriptase, the inhibition is clearly competitive regarding activated DNA template [19] .
It seemed then important to study if the tRNA L y s inhibitory effect was specific towards the HIV encoded DNA polymerase or if other DNA polymerases were also affected. As seen in Figure 2 , the inhibition of mammalian DNA polymerase a by tRNA L v s was equal to that seen with HIV RT while, under the same conditions, AMV reverse transcriptase was not inhibited. Preliminary experiments with animal DNA polymerases y and /3 showed that these enzymes were much less inhibited than DNA polymerase a, while E. coli DNA polymerase I was not affected at all (results not shown). tRNAs on HIV reverse transcriptase activity. As seen in Figure  3 , two groups of tRNAs were found. One group comprising tRNAs specific for valine, glycine and proline did not affect HTV reverse transcriptase activity, while tRNAs specific for phenylalanine, lysine and tryptophan were able to inhibit the enzyme at different degrees, the stronger inhibition beeing obtained with tRNA L v s . A similar study performed with DNA polymerase a using the same tRNAs gave a similar pattern of inhibition (not shown).
In order to assess the ability of other reverse transcriptases, besides HIV RT, to be inhibited by their specific tRNA primers, we performed the experiment described in Figure 4 . As it can be seen in this Figure, tRNA Tr P which is the primer of avian reverse transcriptase, does not inhibit the AMV DNA polymerase activity while markedly decreasing the HTV reverse transcriptase activity.
It is important to point out that the experiments described above were performed with purified tRNA Lys which comprise the three main isoacceptors found in beef liver. By using bidimensionnal electrophoresis we were able to separate and purify the 3 isoacceptors. When assayed separately, the three tRNA L y s forms inhibited very strongly HIV reverse transcriptase : no significant differences in the inhibition degree was obtained for the three seperate isoacceptors (results not shown). In parallel experiments we have found that the complex formation between tRNA L y s and HIV reverse transcriptase, determined by gel retardation assay, was equally found with the three purified isoacceptors, showing that the minor nucleotide changes which characterize the three isoacceptors [30] do not affect their capacity to bind reverse transcriptase (D.R. et al., submitted for publication). Sequence comparison of phenylalanine, lysine and tryptophan tRNAs from animal sources gave no clues on a common motif that could be involved in the inhibition process though there is a relatively high degree of sequence homology [31] . Having shown that tRNA L y s produced the strongest inhibition, we studied the effect of pancreatic ribonuclease (RNase A) and a ribonuclease from Aspergillus oryzae (T ( RNase) on the inhibitory effect of tRNA Lys to ascertain whether the observed effect was due to some structural features of tRNA Lys . In Figure  5 , the RNase A cleavage sites on the three tRNA L y s isoacceptors are shown. It can be seen that while RNAse A leads to very short degradation products, T| RNase which cleaves only at G residues, will lead to a 14-mer in the case of tRNA Figure 6B : Effect of 12-mer and 14-mers on HIV reverse transcriptase DNA polymerase activity. 40 nM HIV RT p66/p51 was assayed in the presence of a gel eluate containing no oligonucleotides (column 1 ; a control without gel eluate gave a similar activity level) or in the presence of 12-mer or 14-mers (columns 2 and 3 respectively). Incubation conditions and the reaction mixture are described in fig. 2 . Oligonucleotides concentration was 6 pM.
by RNase A, which degrades extensively the anticodon region of the three isoacceptors, abolished the inhibitory effect of this tRNA, whereas incubation with Tl RNase, under conditions of complete tRNA digestion, did not affect the inhibitory effect of tRNA L y s (Table 1 ). This result suggests a possible role of the anticodon region in the inhibitory effect. This suggestion was confirmed by the experiment shown in Figure 6A : increasing concentrations of Tl RNase lead to the total digestion of tRNA L y s and the emergence of the 12 and 14-mers fragments corresponding to the anticodon region of this tRNA. When these fragments were separately eluted and their effect assayed on the DNA polymerase activity of HIV reverse transcriptase, a strong inhibiton was obtained as shown in Figure 6B . These results argue in favour of the involvement of the anticodon region of tRNA particles [19] . In experiments performed in collaboration with Drs B. The p66 form of the HIV reverse transcriptase is stimulated by tRNA
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The HIV reverse transcriptase inhibition by its putative primer tRNA may seem paradoxical since reverse transcriptases are supossed to interact with their primer tRNAs as a compulsory step for the initiation of cDNA synthesis. Thus, the HIV RT inhibition by its primer would jeopardize the elongation process catalyzed by the retroviral DNA polymerase. This apparent paradox can be explained by the results obtained when we used a recombinant reverse transcriptase expressed in proteasedeficient yeast cells. The purification procedure used was very similar to that described before [19] but we omitted the FPLC step since the enzyme was rather unstable after the last chromatographic step. As it can be seen in Figure 7A , a decrease of HIV reverse transcriptase specific activity was observed between the phosphocellulose and the heparine-agarose steps. The low specific activity of the HIV RT p66 form can be compared to 02 precursor of the aft avian reverse transcriptase [33] . As seen in Figure 7B , the immunoblot with antibodies against the heterodimeric enzyme showed that the protease deficient yeast cells produced essentially the HIV reverse transcriptase p66 form. Preliminary experiments of our laboratory, as well as the size determination of the p66 form produced in E.coli by other groups [34] [35] [36] , indicate that in the native state the p66 form is found as an homodimer.
Interestingly when the HIV reverse transcriptase p66 form was assayed in the presence of tRNA Lvs , a marked stimulation of DNA synthesis was observed; under the same experimental conditions, the p66-p51 form was inhibited by tRNA synthesis stimulation (values from 3 to 20 fold were obtained).
On the other side, the stimulation was always observed, independent of wether the template used was poly(rA)-oligo(dT), activated DNA or TYMV RNA. When the effect of different tRNAs on the p66 form DNA polymerase activity was studied, we found that phenylalanine, tryptophan and lysine specific tRNAs stimulated the enzymatic activity, while tRNA
Val did not affect it (Table 2) . From these experiments, we can conclude that the tRNAs, capable of stimulating the p66 form, were the same as those involved in the heterodimeric form inhibition.
If we assume that the p66-> p66-p51 proteolysis maturation step occurs in the virion prior to the initiation of cDNA synthesis, it is possible to think that the p66 form may be involved in the selection, and eventually in the annealing of primer tRNA L y s to the PBS. If this is the case, the mature heterodimer p66-p51 would play a role only in the elongation of the annealed tRNA primer. Important modification of the secondary and tertiary structure of tRNA during the annealing to the PBS site may explain that the hybridized primer does not inhibit cDNA synthesis. Further experimental work is necessary to prove this hypothesis.
CONCLUSION
The inhibitory effect of some tRNAs, and more specifically of the anticodon region of tRNA L y s , constitutes a new exciting source in the search of inhibitors of the key enzyme in the replicative cycle of HIV. While we were in the process of writing this article, a recent publication concerning the interactions of HIV RT and bovine tRNA L > s came to our attention [37] . These authors confirm our previous results concerning the formation of a complex between the putative primer tRNA and HIV RT and show that the anticodon region of bovine tRNA L y s interacts strongly with the enzyme. The strong interaction of the anticodon region with the human retroviral polymerase can be related to the inhibition of HIV RT by tRNA 1 -" 5 described in this work, since we have located the inhibitory activity of tRNA precisely in the anticodon region.
The fact that animal cell DNA polymerase a shows the same inhibition pattern by tRNAs as does HIV reverse transcriptase may be a drawback in designing RT inhibitors based on this observation. However this problem can potentially be overcome based on the different compartments where these two enzymes are active in vivo, since retrovirus replication takes place in the cytoplasm while the replicative DNA polymerase a acts in the nucleus in a highly condensed and poorly accessible chromatin complex. Experiments are in progress to delineate both the minimal region of tRNA able to inhibit the enzyme, and also, to target these inhibitory oligonucleotides to the retrovirus replicative complex.
